Table 3. Euglena biomass and glucose induction on gut intestine Rasbora lateristriata (µm)
| Parameter | Treatment |
| C | CN | E1 | GIE1 | GIE2 |
| Muscular thickness | 14.68 ± 1.05c | 13.69 ± 0.19bc | 9.80 ± 0.03a | 10.02 ± 0.02a | 11.27 ± 0.79ab |
| Villus height | 196.56 ± 2.90b | 162.85 ± 2.75a | 285.89 ± 7.87d | 268.59 ± 10.95cd | 239.86 ± 5.77c |
| Villus width | 61.07 ± 1.77ab | 54.17 ± 3.16a | 90.68 ± 1.95d | 789.00 ± 1.06c | 67.94 ± 0.67b |
| Base of intestinal fold | 26.48 ± 0.44b | 32.34 ± 0.74c | 19.17 ± 0.52a | 20.13 ± 0.16a | 20.22 ± 0.27a |
| Intestinal diameter | 625.55 ± 8.49ab | 482.87 ± 24.07a | 802.67 ± 20.97c | 685.20 ± 31.12bc | 661.58 ± 56.56bc |
| Villus circumferences | 1,964.21 ± 26.66ab | 1,516.21 ± 75.56a | 2,520.39 ± 65.85c | 2,151.52 ± 97.72bc | 2,077.35 ± 177.59bc |
Diverse superscript letters in the same row represent significant differences across treatments (p < 0.05; one-way ANOVA, Tukey test).
C, control; CN, control negative; E1, 1% Euglena; GIE1, glucose induction-1% Euglena; GIE2, glucose induction-2% Euglena; ANOVA, analysis of variance.